Home > Insider Trading > Filing (0001225208-11-019292)

Filing Details

Accession Number:: 0001225208-11-019292
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-08-04 17:44:30
Reporting Period:: 2011-08-02

Filing Date:: 2011-08-04
Accepted Time:: 2011-08-04 16:44:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1492426	Horizon Pharma Inc.	HZNP	Pharmaceutical Preparations (2834)	272179987

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1250409	W Jeffrey Bird	755 Page Mill Road, Suite A-200 Palo Alto CA 94304-1005		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-08-02	599,569	$0.00	599,569	No	4	C	Indirect	By Ltd Partnership (SHV)
Common Stock	Acquisiton	2011-08-02	151,617	$9.00	751,186	No	4	C	Indirect	By Ltd Partnership (SHV)
Common Stock	Acquisiton	2011-08-02	138,097	$9.00	889,283	No	4	P	Indirect	By Ltd Partnership (SHV)
Common Stock	Acquisiton	2011-08-02	74,877	$0.00	964,160	No	4	C	Indirect	By Ltd Partnership (SHV)
Common Stock	Acquisiton	2011-08-02	22,711	$0.00	22,711	No	4	C	Indirect	By Trust (Trustees)
Common Stock	Acquisiton	2011-08-02	5,745	$9.00	28,456	No	4	C	Indirect	By Trust (Trustees)
Common Stock	Acquisiton	2011-08-02	5,238	$9.00	33,694	No	4	P	Indirect	By Trust (Trustees)
Common Stock	Acquisiton	2011-08-02	2,868	$0.00	36,562	No	4	C	Indirect	By Trust (Trustees)

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Ltd Partnership (SHV)
No	4	C	Indirect	By Ltd Partnership (SHV)
No	4	P	Indirect	By Ltd Partnership (SHV)
No	4	C	Indirect	By Ltd Partnership (SHV)
No	4	C	Indirect	By Trust (Trustees)
No	4	C	Indirect	By Trust (Trustees)
No	4	P	Indirect	By Trust (Trustees)
No	4	C	Indirect	By Trust (Trustees)

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Convertible Promissory Note	Disposition	2011-08-02	1,364,573	$0.00	151,616	$9.00
Common Stock	Series A Preferred Stock	Disposition	2011-08-02	599,569	$0.00	599,569	$0.00
Common Stock	Series B Preferred Stock	Disposition	2011-08-02	74,877	$0.00	74,877	$0.00
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2011-08-02	6,310	$0.00	6,310	$12.35
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2011-08-02	7,856	$0.00	7,856	$12.35
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2011-08-02	12,542	$0.00	12,542	$12.35
Series A Preferred Stock	Warrant to Purchase Ser A Preferred Stock	Disposition	2011-08-02	14,981	$0.00	14,981	$5.20
Series A Preferred Stock	Warrant to Purchase Ser A Preferred Stock	Disposition	2011-08-02	18,651	$0.00	18,651	$5.20
Series A Preferred Stock	Warrant to Purchase Ser A Preferred Stock	Disposition	2011-08-02	29,775	$0.00	29,775	$5.20
Common Stock	Convertible Promissory Note	Disposition	2011-08-02	51,716	$0.00	5,746	$9.00
Common Stock	Series A Preferred Stock	Disposition	2011-08-02	22,711	$0.00	22,711	$0.00
Common Stock	Series B Preferred Stock	Disposition	2011-08-02	2,868	$0.00	2,868	$0.00
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2011-08-02	239	$0.00	239	$12.35
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2011-08-02	301	$0.00	301	$12.35
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2011-08-02	485	$0.00	485	$12.35
Series A Preferred Stock	Warrant to Purchase Ser A Preferred Stock	Disposition	2011-08-02	568	$0.00	568	$5.20
Series A Preferred Stock	Warrant to Purchase Ser A Preferred Stock	Disposition	2011-08-02	716	$0.00	716	$5.20
Series A Preferred Stock	Warrant to Purchase Ser A Preferred Stock	Disposition	2011-08-02	1,151	$0.00	1,151	$5.20

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		No	4	C	Indirect
0		No	4	C	Indirect
0		No	4	C	Indirect
6,310	2016-07-02	No	4	C	Indirect
7,856	2016-09-25	No	4	C	Indirect
12,542	2015-10-31	No	4	C	Indirect
0	2016-07-02	No	4	C	Indirect
0	2016-09-25	No	4	C	Indirect
0	2015-10-31	No	4	C	Indirect
0		No	4	C	Indirect
0		No	4	C	Indirect
0		No	4	C	Indirect
239	2016-07-02	No	4	C	Indirect
301	2016-09-25	No	4	C	Indirect
485	2015-10-31	No	4	C	Indirect
0	2016-07-02	No	4	C	Indirect
0	2016-09-25	No	4	C	Indirect
0	2015-10-31	No	4	C	Indirect

Footnotes

Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock. Every 2.374 shares of preferred stock converted into one share of common stock upon the closing of the Issuer's initial public offering.
Shares held by Sutter Hill Ventures, A California Limited Partnership. The reporting person is a Managing Director of the General Partner of Sutter Hill Ventures, A California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Represents shares acquired upon conversion, in connection with the Issuer's initial public offering, of convertible promissory notes.
Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Amount shown represents dollars.
Principal and accrued interest converted upon the Issuer's initial public offering of common stock, into shares of common stock.
These securities are preferred stock of the Issuer and did not have an expiration date. Prior to the Issuer's initial public offering of common stock, the securities were convertible at any time at the election of the holder. The securities automatically converted into shares of common stock upon the closing of the Issuer's initial public offering of common stock.
Automatic conversion, in connection with the Issuer's initial public offering, of warrants to purchase Series A Preferred Stock into warrants to purchase Common Stock. The warrants converted at a rate of 2.374 shares of Series A Preferred Stock to 1 share of Common Stock.
The warrants are immediately exercisable and shall terminate on the earlier of the expiration date referenced herein or the occurence of other specified corporate transactions.